GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $455,000 | +15.8% | 2,098 | -38.4% | 0.00% | – |
Q4 2020 | $393,000 | +10.4% | 3,408 | -6.9% | 0.00% | – |
Q3 2020 | $356,000 | -94.0% | 3,662 | -92.5% | 0.00% | -100.0% |
Q2 2020 | $5,972,000 | +8.0% | 48,664 | -22.9% | 0.01% | 0.0% |
Q1 2020 | $5,530,000 | +14.7% | 63,152 | +37.0% | 0.01% | +25.0% |
Q4 2019 | $4,820,000 | +10.2% | 46,095 | +21.2% | 0.00% | 0.0% |
Q3 2019 | $4,375,000 | +375.5% | 38,036 | +612.4% | 0.00% | +300.0% |
Q2 2019 | $920,000 | +11.2% | 5,339 | +8.8% | 0.00% | 0.0% |
Q1 2019 | $827,000 | +72.3% | 4,907 | -0.3% | 0.00% | – |
Q4 2018 | $480,000 | -37.2% | 4,924 | +11.4% | 0.00% | -100.0% |
Q3 2018 | $764,000 | +53.1% | 4,422 | +23.6% | 0.00% | – |
Q2 2018 | $499,000 | +31.0% | 3,579 | +5.8% | 0.00% | – |
Q1 2018 | $381,000 | -15.0% | 3,384 | -0.3% | 0.00% | – |
Q4 2017 | $448,000 | +28.4% | 3,393 | -1.2% | 0.00% | – |
Q3 2017 | $349,000 | +2.6% | 3,434 | +1.1% | 0.00% | – |
Q2 2017 | $340,000 | -45.2% | 3,395 | -33.8% | 0.00% | -100.0% |
Q1 2017 | $621,000 | +31.3% | 5,132 | +21.4% | 0.00% | 0.0% |
Q4 2016 | $473,000 | -52.3% | 4,229 | -43.4% | 0.00% | 0.0% |
Q3 2016 | $991,000 | -16.5% | 7,470 | -42.4% | 0.00% | -50.0% |
Q2 2016 | $1,187,000 | +143.7% | 12,963 | +92.1% | 0.00% | +100.0% |
Q1 2016 | $487,000 | +110.8% | 6,747 | +102.7% | 0.00% | – |
Q4 2015 | $231,000 | -24.0% | 3,328 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $304,000 | -25.7% | 3,328 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $409,000 | +35.0% | 3,328 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $303,000 | +34.7% | 3,328 | 0.0% | 0.00% | – |
Q4 2014 | $225,000 | – | 3,328 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|